Kredorlor #IFB

#IFB Frag Shooter gamer @Diablo3 #starcraft #blacklight Retribution, @Hearthstone , @warships @streaming @archeage @watchpartys

[Kredorlor #IFB @Kredorlor]

Don’t miss out. Come check me out in tiktok https://t.co/jtCBnwQUAu

[Annie @AnnieForTruth]

Absolutely 💯💯🎯

[Occupy Democrats @OccupyDemocrats]

BREAKING: HUGE VICTORY! The Supreme Court crushes Trump's sinister attempt to block states from counting mail-in ballots that arrive after Election Day.

This is a massive win for our democracy...

The court ruled 5-4 that a Mississippi law that affords a grace period for mail-in ballots that arrive late can't be overturned by the White House. The ballots must be postmarked by Election Day and can be received up to five business days later.

Conservative Justices John Roberts and Amy Coney Barrett sided with the liberal justices to protect the law. They were able to point to the Constitution to support their decision since our founding document clearly states that elections are conducted by the states.

One imagines that Trump is particularly incensed by Coney Barrett's defection on this ruling, since he appointed her to the court under the assumption that she would serve as a direct extension of his rule. Instead, she has demonstrated a surprising willingness to buck his interests at times.

The MAGA attempt to invalidate the Mississippi law reveals a nasty truth at the heart of the Republican Party. These fascists know that they can't win elections by appealing to voters since their platform offers nothing but tax cuts for the rich and inane culture war issues. So rather than change their policies to appeal to more voters, their strategy is to reduce the voter pool.

Crucially, this new ruling means that at least 14 other states, including ones with important battleground districts, will be able to enforce their grace period-permitting laws.

This is a ruling worth celebrating. Despite Trump's unhinged rants about mail-in voting, it's a completely reliable and secure means for conducting elections. No study has ever found evidence of mass voter fraud. It's a myth concocted by Republicans to justify their assaults on our democracy.

Please ❤️ and share if you support mail-in voting!

[Willie Ross Jr. Knee Deep @RossKneeDeep]

So, who's the criminal?

[Willie Ross Jr. Knee Deep @RossKneeDeep]

What a loser.

[Heidi 🏖 🐬💙🍹🌊 @Brodiesmom68]

I don’t want to hear a word that it was Biden‘s fault why Trump is in the position he’s in today.
This is all on Trump and the Republicans.

[Governor Newsom Press Office @GovPressOffice]

WOW

[Kredorlor #IFB @Kredorlor]

I love this stuff you should check out our.https://t.co/jEatgBOKyJ #referral

[Ford News @FordJohnathan5]

BREAKINGNEWS: Art of the deal. Iran says Trump agreed to 300 billion to rebuild Iran. 24 billion in frozen assets to be released. Iran claims some of that money has already been handed over. Jesus this is a mess. 🚨

[Brian Krassenstein @krassenstein]

MAJOR BREAKING: In a now deleted post by former MMA fighter Daniel Cormier, he posted screenshots of Eric Trump trying to get an insider scoop on whether any of the MMA fights at the White House are rigged so that he could try and illegally make money off of them..

Below is the Direct Messages that Trump allegedly sent Cormier. There is no reason to doubt the legitimacy of these messages.

[stock setter @MarcJacksonLA]

$HTFL
_Piper Sandler maintains Heartflow 438 target
Overweight
-
$HUM
-Evercore raises Humana target to $370 from $250
In-Line
-
$HUMA
-HC Wainwright raises Humacyte target to $4 from $3
Buy
-
$HUT
-Rosenblatt reiterates Hut 8 $124 target
Buy
-

[Democrats @TheDemocrats]

What?

[Lovable Liberal and his Old English sheepdog @DougWahl1]

I am impressed!

I was sure Donald Trump would never post anything about pride month. And then he posted this!

Clearly, I was wrong!

[Rick Wilson @TheRickWilson]

Happy Pride! 🏳️‍🌈

[Democratic Wins Media @DemocraticWins]

BREAKING: In a stunning coup against Ken Paxton, the Houston Chronicle, one of the largest papers in Texas, just endorsed James Talarico. Let's go!

[Humacyte @humacyte]

As we continue to recognize American Stroke Awareness Month, we’re sharing a reminder of how central vascular health is across all cardiovascular care.

In the United States, cardiovascular disease remains the leading cause of death, accounting for nearly one in every three deaths nationwide.¹

Each year, hundreds of thousands of people undergo cardiac procedures to restore or support blood flow—underscoring the critical role of healthy, reliable vasculature throughout care.

Adult cardiac surgery is tracked at remarkable scale through the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database, one of the most comprehensive clinical registries in medicine.² The STS Database includes more than nine million procedures, capturing the vast majority of adult cardiac surgeries performed in the U.S.² In the most recent fully reported year (2022), the database captured 278,202 adult cardiac surgery procedures.²

Together, these data reinforce why vascular health is foundational not only to stroke prevention and response, but also to cardiac surgery, trauma care, and complex vascular intervention.

At Humacyte, we are deeply focused on vascular health—and on advancing regenerative innovations designed to support blood flow where it matters most, across trauma and complex vascular care.

Learn more about Humacyte and our groundbreaking science https://t.co/9vMVYqzsCG

References
1. Centers for Disease Control and Prevention. Heart Disease Facts. Updated October 24, 2024. Accessed May 2026. https://t.co/mKUIzbkHBV [https://t.co/5OWtu9DFz9]

2. Wyler von Ballmoos MC, Kaneko T, Iribarne A, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2023 update on procedure data and research. Ann Thorac Surg. 2024;117(2):260‑270. doi:10.1016/j.athoracsur.2023.11.016 [annalsthor...urgery.org]

Trademarks are property of Humacyte Global, Inc.
© 2026 Humacyte Global Inc. All Rights Reserved.
#AmericanStrokeMonth #VascularHealth #CardiovascularCare #CardiacSurgery #MedTech #MedicalInnovation #HealthcareInnovation #VascularSurgery #RegenerativeMedicine #Humacyte

[Humacyte @humacyte]

On Trauma Survivors Day, May 20th, we honor the strength and resilience of trauma survivors—and the clinicians, caregivers, and first responders who support recovery when it matters most. Every person involved and tool used to save lives and improve recovery is critical in the healing journey.

At Humacyte, we are incredibly proud to advance Symvess® acellular tissue engineered vessel-tyod (ATEV), a human derived bioengineered vessel developed to support urgent arterial injury repair.

We remain focused on innovation in emergency care. Our clinical data includes civilian use in the United States and Israel, and real‑world military applications during the war in Ukraine where urgent vascular reconstruction can make a difference between limb salvage and loss. Research and clinical experience are critical and have helped expand understanding of how innovative vascular solutions may support limb salvage and recovery after severe injuries.

Today, we recognize survivors—and reaffirm our commitment to advancing care that supports healing after trauma.

WATCH Devin’s Story, a real patient and ATEV recipient, by SCROLLING TO THE BOTTOM of the page of page at https://t.co/pk29kAkneN.

CLICK HERE>>> https://t.co/YOMJ7Qsyel

PLEASE SEE IMPORTANT SAFETY INFORMATION INCLUDING THE BOXED WARNING,
AND FULL PRESCRIBING INFORMATION at https://t.co/Eg2XmrWRso

INDICATION
SYMVESS is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.

BOXED WARNING: GRAFT FAILURE- Loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage.

DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy after acute injury resolution.

WARNINGS AND PRECAUTIONS: Vascular Graft Rupture, Anastomotic Failure, and Thrombosis have occurred in patients treated with SYMVESS. SYMVESS is manufactured using cells and reagents that may transmit infectious diseases or agents; none have been reported during clinical testing.

ADVERSE REACTIONS: most common (≥3%): thrombosis, fever, pain, anastomotic stenosis, rupture or anastomotic failure, and infection.

Trademarks are property of Humacyte Global, Inc
© 2026 Humacyte Global Inc. All Rights Reserved. US-SYM-000346

#VascularInjury #MedicalInnovation #Symvess #Humacyte #Trauma #TraumaSurvivorsDay #NTSD #TraumaSurvivors

[DustyWhy @_dustinwest]

SOOOO @Alistair_McF I'VE GOT A CRAZY OPPORTUNITY FOR YOU MY BROTHER @AshesofCreation

[James Tate @JamesTate121]

FYI you poor red states, we support you.

[Leading Report @LeadingReport]

BREAKING: Illinois Gov. JB Pritzker signs bill legalizing assisted dy*ng.